• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Comprehensive Guide to 1H-Pyrrolo[3,2-c]pyridin-3-amine (CAS No. 1000342-62-0): Properties, Applications, and Market Insights

1H-Pyrrolo[3,2-c]pyridin-3-amine (CAS No. 1000342-62-0) is a heterocyclic organic compound that has garnered significant attention in pharmaceutical and materials science research. This nitrogen-containing fused ring system serves as a crucial building block for drug discovery and advanced material development. With its unique pyrrolopyridine scaffold, this compound offers remarkable versatility in medicinal chemistry applications.

The molecular structure of 1H-Pyrrolo[3,2-c]pyridin-3-amine features a fused bicyclic system combining pyrrole and pyridine rings, with an amine group at the 3-position. This specific arrangement contributes to its electron-rich character and makes it particularly valuable for designing kinase inhibitors and other biologically active molecules. Researchers are increasingly exploring its potential in developing treatments for neurological disorders and inflammatory conditions.

In pharmaceutical applications, 1H-Pyrrolo[3,2-c]pyridin-3-amine derivatives have shown promise as selective kinase modulators. The compound's ability to interact with various biological targets stems from its hydrogen bonding capacity and aromatic stacking properties. Recent studies highlight its potential in developing next-generation cancer therapeutics, particularly in targeting specific oncogenic pathways while minimizing side effects.

The synthesis of 1H-Pyrrolo[3,2-c]pyridin-3-amine typically involves multi-step organic transformations, with researchers continuously optimizing routes for better yields and purity. Advanced catalytic methods and green chemistry approaches are being applied to improve the sustainability of its production. The compound's structure-activity relationships are a subject of ongoing investigation, particularly in the context of drug design optimization.

From a materials science perspective, 1H-Pyrrolo[3,2-c]pyridin-3-amine serves as a precursor for organic electronic materials. Its conjugated π-system and electron-donating amine group make it attractive for developing organic semiconductors and light-emitting materials. Researchers are exploring its incorporation into OLED technologies and molecular sensors, capitalizing on its unique photophysical properties.

The global market for 1H-Pyrrolo[3,2-c]pyridin-3-amine reflects growing demand from both pharmaceutical and specialty chemicals sectors. With increasing investment in small molecule drug discovery and personalized medicine, this compound has seen rising procurement from research institutions and pharmaceutical companies. Suppliers are responding by improving scale-up processes and developing high-purity grades to meet diverse research needs.

Quality control of 1H-Pyrrolo[3,2-c]pyridin-3-amine typically involves advanced analytical techniques including HPLC analysis, mass spectrometry, and NMR characterization. These methods ensure the compound meets stringent purity requirements for research applications. Storage recommendations generally suggest anhydrous conditions and protection from light to maintain stability over extended periods.

Recent scientific literature highlights novel applications of 1H-Pyrrolo[3,2-c]pyridin-3-amine scaffolds in developing proteolysis targeting chimeras (PROTACs) and other targeted protein degradation technologies. This emerging therapeutic modality represents one of the most exciting applications of this chemical scaffold in modern drug discovery pipelines.

For researchers working with 1H-Pyrrolo[3,2-c]pyridin-3-amine, proper handling procedures and safety protocols should always be followed. While not classified as hazardous under standard conditions, standard laboratory precautions for organic compounds should be maintained. Material Safety Data Sheets (MSDS) should be consulted for specific handling information.

The future outlook for 1H-Pyrrolo[3,2-c]pyridin-3-amine research appears promising, with several clinical candidates containing this scaffold currently in development. Its versatility continues to inspire new applications across multiple scientific disciplines, from medicinal chemistry to materials engineering. As synthetic methodologies advance and biological understanding deepens, this compound is poised to play an increasingly important role in scientific innovation.

• 79642-26-5(5H-Pyrido[4,3-b]indol-6-amine)
• 874498-26-7(3,5-Quinolinediamine)
• 184485-83-4(1H-Indole-4,7-diamine)
• 53867-98-4(4,8-Quinolinediamine(9CI))
• 71692-41-6(1H-Benz[g]indol-3-amine)
• 1190320-10-5(1H-pyrrolo[2,3-c]pyridin-4-amine)
• 53454-30-1(1,6-Naphthyridin-3-amine)
• 1092960-99-0(3-Amino-6-Azaindole)
• 57778-93-5(1H-Indol-3-amine Hydrochloride)
• 7250-19-3(1H-Indol-3-amine)